http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113252911-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2021-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113252911-B |
| titleOfInvention | Detection kit for SARS-CoV-2 neutralizing antibody and its application |
| abstract | The invention relates to the field of antibody detection, and in particular, provides a SARS-CoV-2 neutralizing antibody detection kit and application thereof. The detection kit uses a competitive method to detect SARS-CoV-2 neutralizing antibodies. By simultaneously applying SARS-CoV-2 RBD protein and NTD protein two antigens to simulate the action site of virus infection, neutralizing antibodies can compete Block the binding of ACE2 receptor protein and AXL receptor protein to the action site, so as to realize the detection of neutralizing antibody. |
| priorityDate | 2021-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.